Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
Hao Zi(Hubei University of Medicine), Xian‐Tao Zeng(Fujian Medical University), Jiao Huang(Wuhan University), Tong-Zu Liu(Wuhan University), Yi-Tong Li(Hubei University of Arts and Science), Hanghang Luan(Wuhan University), Yuanyuan Zhang(Sichuan University), Fan Yu(Peking University), Yongbo Wang(Wuhan University), Qiao Huang(Wuhan University), Danqi Wang(Jiangnan University), Hang Zheng(Anhui Agricultural University), Pengcheng Luo(Wuhan University), Ren-Peng Yu(Wuhan University), Mengyang Liu(Wuhan University)
Cited by 135
Related Papers
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)
|Military Medical Research|2020|2.4k
Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?
|Military Medical Research|2020|1.6k
Perceived infection transmission routes, infection control practices, psychosocial changes, and management of COVID-19 infected healthcare workers in a tertiary acute care hospital in Wuhan: a cross-sectional survey
|Military Medical Research|2020|203
Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019
|Military Medical Research|2021|168